Fidelity Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Fidelity Investments’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$934M	Buy	23,642,990 +29,405	+0.1%	+$1.16M	0.05%	293
2025 Q1	$712M	Buy	23,613,585 +924,094	+4%	+$27.9M	0.05%	332
2024 Q4	$793M	Buy	22,689,491 +209,962	+0.9%	+$7.34M	0.05%	320
2024 Q3	$901M	Buy	22,479,529 +584,723	+3%	+$23.4M	0.05%	296
2024 Q2	$1.04B	Buy	21,894,806 +32,071	+0.1%	+$1.53M	0.07%	240
2024 Q1	$948M	Buy	21,862,735 +341,863	+2%	+$14.8M	0.06%	274
2023 Q4	$1.09B	Buy	21,520,872 +21,950	+0.1%	+$1.11M	0.08%	210
2023 Q3	$975M	Buy	21,498,922 +35,106	+0.2%	+$1.59M	0.08%	207
2023 Q2	$881M	Buy	21,463,816 +27,482	+0.1%	+$1.13M	0.07%	237
2023 Q1	$766M	Buy	21,436,334 +128,815	+0.6%	+$4.6M	0.07%	287
2022 Q4	$805M	Buy	21,307,519 +16,360	+0.1%	+$618K	0.08%	244
2022 Q3	$942M	Buy	21,291,159 +21,599	+0.1%	+$955K	0.1%	183
2022 Q2	$787M	Sell	21,269,560 -51,326	-0.2%	-$1.9M	0.08%	236
2022 Q1	$790M	Buy	21,320,886 +139,384	+0.7%	+$5.16M	0.06%	299
2021 Q4	$645M	Buy	21,181,502 +9,348	+0%	+$284K	0.05%	365
2021 Q3	$710M	Buy	21,172,154 +27,699	+0.1%	+$929K	0.06%	316
2021 Q2	$843M	Buy	21,144,455 +50,559	+0.2%	+$2.02M	0.07%	269
2021 Q1	$948M	Buy	21,093,896 +155,862	+0.7%	+$7.01M	0.08%	229
2020 Q4	$1.18B	Buy	20,938,034 +71,082	+0.3%	+$4.02M	0.11%	179
2020 Q3	$990M	Buy	20,866,952 +56,398	+0.3%	+$2.68M	0.1%	184
2020 Q2	$1.23B	Sell	20,810,554 -149,673	-0.7%	-$8.82M	0.13%	134
2020 Q1	$991M	Hold	20,960,227	–	–	0.14%	140
2019 Q4	$1.27B	Buy	20,960,227 +24,443	+0.1%	+$1.48M	0.14%	140
2019 Q3	$1.25B	Buy	20,935,784 +26,522	+0.1%	+$1.59M	0.15%	133
2019 Q2	$1.34B	Buy	20,909,262 +275,564	+1%	+$17.7M	0.16%	120
2019 Q1	$1.67B	Buy	20,633,698 +123,948	+0.6%	+$10.1M	0.2%	91
2018 Q4	$1.11B	Buy	20,509,750 +45,911	+0.2%	+$2.48M	0.15%	126
2018 Q3	$1.06B	Buy	20,463,839 +1,635,782	+9%	+$84.4M	0.12%	157
2018 Q2	$785M	Buy	18,828,057 +17,575	+0.1%	+$732K	0.09%	209
2018 Q1	$829M	Buy	18,810,482 +91,157	+0.5%	+$4.02M	0.1%	204
2017 Q4	$942M	Buy	18,719,325 +66,122	+0.4%	+$3.33M	0.11%	193
2017 Q3	$946M	Buy	18,653,203 +58,369	+0.3%	+$2.96M	0.11%	183
2017 Q2	$946M	Buy	18,594,834 +32,414	+0.2%	+$1.65M	0.12%	190
2017 Q1	$746M	Buy	18,562,420 +381,975	+2%	+$15.4M	0.09%	223
2016 Q4	$870M	Buy	18,180,445 +42,591	+0.2%	+$2.04M	0.12%	185
2016 Q3	$665M	Buy	18,137,854 +20,406	+0.1%	+$748K	0.09%	243
2016 Q2	$422M	Buy	18,117,448 +325,351	+2%	+$7.58M	0.06%	360
2016 Q1	$721M	Buy	17,792,097 +81,140	+0.5%	+$3.29M	0.1%	210
2015 Q4	$1.1B	Buy	17,710,957 +23,310	+0.1%	+$1.44M	0.15%	143
2015 Q3	$715M	Buy	17,687,647 +37,345	+0.2%	+$1.51M	0.1%	206
2015 Q2	$1.02B	Buy	17,650,302 +104,252	+0.6%	+$6M	0.13%	166
2015 Q1	$1.12B	Buy	17,546,050 +14,317	+0.1%	+$912K	0.14%	152
2014 Q4	$1.08B	Sell	17,531,733 -18,000	-0.1%	-$1.11M	0.14%	154
2014 Q3	$681M	Hold	17,549,733	–	–	0.09%	245
2014 Q2	$605M	Hold	17,549,733	–	–	0.08%	283
2014 Q1	$758M	Buy	17,549,733 +592,014	+3%	+$25.6M	0.11%	203
2013 Q4	$676M	Sell	16,957,719 -30,000	-0.2%	-$1.2M	0.1%	233
2013 Q3	$638M	Buy	16,987,719 +765,455	+5%	+$28.7M	0.1%	241
2013 Q2	$436M	Buy	+16,222,264	New	+$436M	0.07%	317